SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-216928
Filing Date
2021-07-16
Accepted
2021-07-16 07:06:34
Documents
12
Period of Report
2021-07-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d122668d8k.htm   iXBRL 8-K 27384
  Complete submission text file 0001193125-21-216928.txt   147228

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20210713.xsd EX-101.SCH 2882
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20210713_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20210713_pre.xml EX-101.PRE 10946
5 EXTRACTED XBRL INSTANCE DOCUMENT d122668d8k_htm.xml XML 3233
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 211094259
SIC: 2836 Biological Products, (No Diagnostic Substances)